- Home
- AVGR vs SONN Comparison
AVGR vs SONN Comparison
Compare AVGR & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVGR
- SONN
- Stock Information
- Founded
- AVGR 2007
- SONN N/A
- Country
- AVGR United States
- SONN United States
- Employees
- AVGR N/A
- SONN N/A
- Industry
- AVGR Medical/Dental Instruments
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- AVGR Health Care
- SONN Health Care
- Exchange
- AVGR Nasdaq
- SONN Nasdaq
- Market Cap
- AVGR 2.6M
- SONN 2.5M
- IPO Year
- AVGR 2015
- SONN N/A
- Fundamental
- Price
- AVGR $0.56
- SONN $1.62
- Analyst Decision
- AVGR Strong Buy
- SONN Strong Buy
- Analyst Count
- AVGR 1
- SONN 2
- Target Price
- AVGR $5.00
- SONN $38.00
- AVG Volume (30 Days)
- AVGR 877.5K
- SONN 282.7K
- Earning Date
- AVGR 03-19-2025
- SONN 02-12-2025
- Dividend Yield
- AVGR N/A
- SONN N/A
- EPS Growth
- AVGR N/A
- SONN N/A
- EPS
- AVGR N/A
- SONN N/A
- Revenue
- AVGR $7,262,000.00
- SONN $18,626.00
- Revenue This Year
- AVGR N/A
- SONN N/A
- Revenue Next Year
- AVGR $93.49
- SONN N/A
- P/E Ratio
- AVGR N/A
- SONN N/A
- Revenue Growth
- AVGR N/A
- SONN N/A
- 52 Week Low
- AVGR $0.39
- SONN $1.41
- 52 Week High
- AVGR $5.45
- SONN $18.72
- Technical
- Relative Strength Index (RSI)
- AVGR 43.82
- SONN 42.90
- Support Level
- AVGR $0.50
- SONN $1.64
- Resistance Level
- AVGR $0.65
- SONN $2.05
- Average True Range (ATR)
- AVGR 0.06
- SONN 0.17
- MACD
- AVGR 0.00
- SONN 0.03
- Stochastic Oscillator
- AVGR 32.90
- SONN 24.59
About AVGR Avinger Inc.
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.